E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells - PubMed (original) (raw)

Affiliations

PMID: 8423986

E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells

A Strasser et al. Oncogene. 1993 Jan.

Abstract

To assess the lymphoid tumorigenic potential of bcl-2, mice of five independent strains expressing a bcl-2 transgene in B and/or T cells were monitored for disease up to 12 months of age. Lymphoma prevalence was minimal in the T lineage but significant, although low (3-15%), in the B lineage. The principal types of tumors were plasmacytomas secreting immunoglobulin and novel lymphomas that expressed markers such as Sca-1, CD4, Thy-1, CD34 and CD45(B220), consistent with an origin very early in B-lymphoid development. Rearrangement of the c-myc gene was common in the plasmacytomas, implying a synergistic role for myc and bcl-2 in their etiology, but was not detected in the lymphomas.

PubMed Disclaimer

Cited by

Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.
Srivastava RK, Sasaki CY, Hardwick JM, Longo DL. Srivastava RK, et al. J Exp Med. 1999 Jul 19;190(2):253-65. doi: 10.1084/jem.190.2.253. J Exp Med. 1999. PMID: 10432288 Free PMC article.
Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
Kelly PN, Puthalakath H, Adams JM, Strasser A. Kelly PN, et al. Blood. 2007 Jun 1;109(11):4907-13. doi: 10.1182/blood-2006-10-051847. Epub 2007 Feb 22. Blood. 2007. PMID: 17317859 Free PMC article.
Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.
Angileri F, Morrow G, Roy V, Orejuela D, Tanguay RM. Angileri F, et al. Cancers (Basel). 2014 Apr 23;6(2):998-1019. doi: 10.3390/cancers6020998. Cancers (Basel). 2014. PMID: 24762634 Free PMC article.
Immunopathology of apoptosis--introduction and overview.
Vaux DL. Vaux DL. Springer Semin Immunopathol. 1998;19(3):271-8. doi: 10.1007/BF00787224. Springer Semin Immunopathol. 1998. PMID: 9540156 Review. No abstract available.
AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.
Kovalchuk AL, duBois W, Mushinski E, McNeil NE, Hirt C, Qi CF, Li Z, Janz S, Honjo T, Muramatsu M, Ried T, Behrens T, Potter M. Kovalchuk AL, et al. J Exp Med. 2007 Nov 26;204(12):2989-3001. doi: 10.1084/jem.20070882. Epub 2007 Nov 6. J Exp Med. 2007. PMID: 17998390 Free PMC article.

E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells - PubMed (original) (raw)